Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.R.6973
H.R.6973: Enhanced Access to Affordable Medicines Act of 2022
About This Bill
- This bill was introduced in the 117th Congress
- This bill is primarily about health
- Introduced March 8, 2022
- Latest Major Action March 9, 2022
Bill Sponsor
Bill Cosponsor
Bill Version
- Introduced in House - March 8, 2022
Bill Summary
Enhanced Access to Affordable Medicines Act of 2022 This bill specifies that the Food and Drug Administration may approve generic drugs with different labels than the brand-name versions if, among other requirements, the brand-name drug is subject to an active patent or exclusivity period and a revised label for the brand-name drug is approved within 90 days (rather than 60 days) of the expiration of the patent or exclusivity period.
(Source: Library of Congress)
Bill Actions
| Date | Description |
|---|---|
| March 9, 2022 |
Referred to the Subcommittee on Health.
|
| March 8, 2022 |
Referred to the House Committee on Energy and Commerce.
|
| March 8, 2022 |
Introduced in the House by Buddy Carter (R-Ga.) |